 remission membranous glomerulonephritis cyclophosphamide prednisone OBJECTIVE effect cyclophosphamide prednisone progressive renal failure nephrotic features patients membranous glomerulonephritis DESIGN Prospective nonrandomized time series SETTING Outpatient clinic university medical center PATIENTS Eleven consecutive patients biopsy-proven membranous glomerulonephritis plasma creatinine levels months INTERVENTION Cyclophosphamide prednisone ten patients patient MEASUREMENTS MAIN RESULTS ten patients agents median plasma creatinine mumol/L mg/dL months treatment mumol/L mg/dL CI mumol/L combined therapy months median plasma creatinine mumol/L mg/dL median decline mumol/L mg/dL CI mumol/L Pretreatment plasma creatinine levels mumol/L mg/dL ten patients months stable patients months therapy median urine protein excretion g/d months therapy ten patients g/d CI g/d median plasma albumin g/L g/L CI g/L median plasma cholesterol mumol/L mg/dL mumol/L mg/dL CI mumol/L patient relapse months therapy re-treatment renal function nephrotic variables normal eleventh patient cyclophosphamide course similar combined therapy group CONCLUSION Cyclophosphamide prednisone prolonged remissions membranous glomerulonephritis renal function